CARMAT announces the first commercial implant of its Aeson artificial heart

Health News
FILE PHOTO: An artificial heart by French manufacturer Carmat is seen during an interview with Reuters in Velizy, near Paris, January 11, 2021. REUTERS/Christian Hartmann

PARIS (Reuters) – French artificial heartmaker CARMAT announced on Monday the first commercial implant of its Aeson artificial heart at a hospital in Italy, which the company said paved the way for its further commercial development.

Last week, CARMAT had announced the first human implant of its Aeson bioprosthetic artificial heart in the United States.

Source: Read Full Article

Related posts:
  1. benzac acne solutions target
  2. Eli Lilly's antibody combination receives FDA emergency use authorization for COVID-19
  3. UK startup develops gyroscope glove to ease tremors for those with Parkinson's
  4. EU expects to vaccinate majority by end-June – Bloomberg
  5. Nine in 10 Spaniards would use digital health passes to travel, survey shows